OECD highlights the progress made in laboratory systems in the EU/EEA since the implementation of EULabCap
The OECD report ‘Health at a Glance: Europe 2018’ summarises the EULabCap indicator results in the chapter on public health laboratory capacity to control infectious disease threats.
ECDC comment: European Commission updates communicable disease surveillance list - Lyme neuroborreliosis now under EU/EEA surveillance
ECDC will start monitoring disease distribution in the EU and collecting EU data through the epidemiological surveillance network comprising the European Commission, ECDC and national authorities for epidemiological surveillance.
The benefits of HIV treatment: undetectable means you do not pass on the virus
Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
WHO recommendations for influenza virus vaccine composition for the 2018-2019 Northern hemisphere season
On 19-21 February 2018 the World Health Organization (WHO) agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2018-2019 influenza season.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
Taking stock: where does Europe stand in the elimination of hepatitis B and C?
In 2016, a regional action plan for Europe that aims to contribute to the implementation of the global viral hepatitis elimination strategy was developed by the WHO Regional Office for Europe. In an article published today in Eurosurveillance, the authors take a closer look how Europe is doing according to the ten indicators and targets outlined in this plan. In short: Europe still has some way to go if it wants to eliminate viral hepatitis by 2030.
Mutation of avian influenza A(H7N9): now highly pathogenic for poultry but risk of human-to-human transmission remains low
The upsurge of human cases in China during the winter 2016-2017 due to A(H7N9) gives cause for concern.